LIVETech & Science1 votes· 1d ago

If a psychedelic-based medicine for depression were approved, how open would you be to trying it?

Drugmaker Eli Lilly is reportedly in talks to acquire a biotech developing a fast-acting, psychedelic-inspired nasal spray for treatment-resistant depression.

Grab this poll for your site

Votes cast anywhere this poll is embedded count toward the same live total.

<iframe src="https://groundbeat.com/embed/907" width="100%" height="420" frameborder="0" style="max-width:520px;border-radius:14px;"></iframe>
Sponsored

Discussion (0)

Be the first to weigh in.

More in Tech & Science

If a psychedelic-based medicine for depression were approved, how open would you be to trying it? — Groundbeat